Loading...
ASPI logo

ASP Isotopes Inc.NasdaqCM:ASPI Stock Report

Market Cap US$1.0b
Share Price
US$7.55
US$13
41.9% undervalued intrinsic discount
1Y-14.6%
7D13.2%
1D
Portfolio Value
​
View

ASP Isotopes Inc.

NasdaqCM:ASPI Stock Report

Market Cap: US$1.0b

ASP Isotopes (ASPI) Stock Overview

A development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. More details

ASPI fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 49.28% per year

Analysts in good agreement that stock price will rise by 72.2%

Risk Analysis

Shareholders have been substantially diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the US market


ASPI Community Fair Values

Create Narrative

See what 49 others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

ASP Isotopes Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for ASP Isotopes
Historical stock prices
Current Share PriceUS$7.55
52 Week HighUS$14.49
52 Week LowUS$3.92
Beta3.27
1 Month Change46.32%
3 Month Change47.75%
1 Year Change-14.59%
3 Year Change1,913.33%
5 Year Changen/a
Change since IPO182.77%

Recent News & Updates

Seeking Alpha • May 28

ASP Isotopes: The Long Road From Isotopes To Income

Summary ASP Isotopes (ASPI) is rated Sell due to premature growth narrative, high capital intensity, and heavy execution risk versus current $6.89 share price. My DCF valuation implies a $2.40 fair value, reflecting the need for ASPI to prove commercial scale, margin conversion, and financing capacity. Recent business updates show segment progress—radiopharma leads revenue, Si-28 and Yb-176 shipments targeted for 2026, and Renergen Phase 1 drilling completed early. Despite $290.5M liquidity, ASPI faces negative cash flow, widening losses, and a 25% probability of failure, making current risk-reward unattractive. Read the full article on Seeking Alpha

Recent updates

Seeking Alpha • May 28

ASP Isotopes: The Long Road From Isotopes To Income

Summary ASP Isotopes (ASPI) is rated Sell due to premature growth narrative, high capital intensity, and heavy execution risk versus current $6.89 share price. My DCF valuation implies a $2.40 fair value, reflecting the need for ASPI to prove commercial scale, margin conversion, and financing capacity. Recent business updates show segment progress—radiopharma leads revenue, Si-28 and Yb-176 shipments targeted for 2026, and Renergen Phase 1 drilling completed early. Despite $290.5M liquidity, ASPI faces negative cash flow, widening losses, and a 25% probability of failure, making current risk-reward unattractive. Read the full article on Seeking Alpha
Seeking Alpha • Jan 25

ASP Isotopes: Too Hot To Handle

Summary ASP Isotopes Inc. is rated a sell for retail value investors due to price volatility, significant losses, heavy spending on SG&A over R&D, and other risks. The company’s dilution of shareholders and increasing debt are red flags. ASP’s small workforce and high market cap raise concerns, especially given the competitive landscape. Company operations are in South Africa and Iceland, hardly known for their high-tech product market share and tech workforces. Read the full article on Seeking Alpha

Shareholder Returns

ASPIUS ChemicalsUS Market
7D13.2%-1.6%0.3%
1Y-14.6%4.9%26.2%

Return vs Industry: ASPI underperformed the US Chemicals industry which returned 4.9% over the past year.

Return vs Market: ASPI underperformed the US Market which returned 26.2% over the past year.

Price Volatility

Is ASPI's price volatile compared to industry and market?
ASPI volatility
ASPI Average Weekly Movement16.3%
Chemicals Industry Average Movement7.2%
Market Average Movement7.2%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: ASPI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: ASPI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2021271Paul Elliot Mannaspisotopes.com

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market.

ASP Isotopes Inc. Fundamentals Summary

How do ASP Isotopes's earnings and revenue compare to its market cap?
ASPI fundamental statistics
Market capUS$1.05b
Earnings (TTM)-US$193.11m
Revenue (TTM)US$26.93m
35.3x
P/S Ratio
-4.9x
P/E Ratio

Is ASPI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ASPI income statement (TTM)
RevenueUS$26.93m
Cost of RevenueUS$22.18m
Gross ProfitUS$4.74m
Other ExpensesUS$197.85m
Earnings-US$193.11m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-1.53
Gross Margin17.62%
Net Profit Margin-717.16%
Debt/Equity Ratio86.4%

How did ASPI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 14:47
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ASP Isotopes Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
George GianarikasCanaccord Genuity
null nullCantor Fitzgerald & Co.
Derek SoderbergCantor Fitzgerald & Co.